T136. Safety and Efficacy of Intravenous Ganaxolone in Severe Postpartum Depression: Results From a Double-Blind, Placebo-Controlled Phase 2 Study

Rolando Gutierrez-Esteinou; Bassem Maximos; Robert Riesenberg; Kimball A. Johnson; Alex Aimetti; Jaako Lappalainen; Lorianne Masuoka

doi:10.1016/j.biopsych.2019.03.459

T136. Safety and Efficacy of Intravenous Ganaxolone in Severe Postpartum Depression: Results From a Double-Blind, Placebo-Controlled Phase 2 Study

Biological Psychiatry ◽

10.1016/j.biopsych.2019.03.459 ◽

2019 ◽

Vol 85 (10) ◽

pp. S181-S182

Author(s):

Rolando Gutierrez-Esteinou ◽

Bassem Maximos ◽

Robert Riesenberg ◽

Kimball A. Johnson ◽

Alex Aimetti ◽

...

Keyword(s):

Postpartum Depression ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

A multinational, randomized, double-blind, placebo-controlled Phase 2 study to assess safety and efficacy of olesoxime in Type 2 or non-ambulatory Type 3 spinal muscular atrophy

Neuromuscular Disorders ◽

10.1016/s0960-8966(17)30304-8 ◽

2017 ◽

Vol 27 ◽

pp. S29

Author(s):

J. Buchbjerg ◽

E. Bertini ◽

E. Dessaud ◽

E. Mercuri ◽

F. Muntoni ◽

...

Keyword(s):

Spinal Muscular Atrophy ◽

Muscular Atrophy ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Phase 2 Study ◽

Type 3

Download Full-text

(409) A Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety and Efficacy of NYX-2925 in Subjects with Painful Diabetic Peripheral Neuropathy

Journal of Pain ◽

10.1016/j.jpain.2019.02.094 ◽

2019 ◽

Vol 20 (4) ◽

pp. S73 ◽

Cited By ~ 1

Author(s):

S. Torri ◽

S. Sainati ◽

M. Burak ◽

J. Hamilton ◽

N. Katz ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Diabetic Peripheral Neuropathy ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Painful Diabetic Peripheral Neuropathy ◽

Phase 2 Study

Download Full-text

Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)

American Heart Journal ◽

10.1016/j.ahj.2020.01.009 ◽

2020 ◽

Vol 222 ◽

pp. 183-190 ◽

Cited By ~ 5

Author(s):

James E. Udelson ◽

Gregory D. Lewis ◽

Sanjiv J. Shah ◽

Michael R. Zile ◽

Margaret M. Redfield ◽

...

Keyword(s):

Heart Failure ◽

Soluble Guanylate Cyclase ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Phase 2 Study ◽

Patients With Heart Failure ◽

Soluble Guanylate Cyclase Stimulator

Download Full-text

SAT0089 SAFETY AND EFFICACY OF LY3337641, A BRUTON’S TYROSINE KINASE INHIBITOR IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-PART PHASE 2 STUDY

10.1136/annrheumdis-2019-eular.2672 ◽

2019 ◽

Cited By ~ 1

Author(s):

Mark C. Genovese ◽

Alberto Spindler ◽

Akira Sagawa ◽

Won Park ◽

Anna Dudek ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Phase 2 ◽

Double Blind ◽

Bruton's Tyrosine Kinase ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE‐TPA): A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Study

Annals of Neurology ◽

10.1002/ana.25644 ◽

2019 ◽

Vol 87 (2) ◽

pp. 233-245 ◽

Cited By ~ 4

Author(s):

Jong S. Kim ◽

Kyung Bok Lee ◽

Jong‐Ho Park ◽

Sang Min Sung ◽

Kyungmi Oh ◽

...

Keyword(s):

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Faculty Opinions recommendation of P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725255169.793503497 ◽

2015 ◽

Author(s):

Brendan J Canning

Keyword(s):

Receptor Antagonist ◽

Chronic Cough ◽

Phase 2 ◽

P2x3 Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734506216.793579336 ◽

2020 ◽

Author(s):

Nathalie Gaspar

Keyword(s):

Adult Patients ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Metastatic Osteosarcoma ◽

Phase 2 Study

Download Full-text

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study

British Journal of Cancer ◽

10.1038/s41416-021-01356-3 ◽

2021 ◽

Author(s):

Ying Cheng ◽

Qiming Wang ◽

Kai Li ◽

Jianhua Shi ◽

Ying Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

The Lancet Neurology ◽

10.1016/s1474-4422(14)70209-1 ◽

2014 ◽

Vol 13 (11) ◽

pp. 1100-1107 ◽

Cited By ~ 225

Author(s):

David W Dodick ◽

Peter J Goadsby ◽

Stephen D Silberstein ◽

Richard B Lipton ◽

Jes Olesen ◽

...

Keyword(s):

Episodic Migraine ◽

Calcitonin Gene Related Peptide ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Related Peptide ◽

Phase 2 Trial ◽

Calcitonin Gene

Download Full-text

SAT0110 Efficacy and Safety of Pateclizumab (Anti-Lymphotoxin-Alpha) in Dmard-Ir Patients: Results of a Randomized, Double-Blind, Placebo-Controlled Head-To-Head Phase 2 Study with Adalimumab

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1836 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A617.2-A618

Author(s):

W. Kennedy ◽

P. Horn ◽

Z. Su ◽

K. Basu ◽

A. Herman ◽

...

Keyword(s):

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study ◽

Lymphotoxin Alpha

Download Full-text